In Focus:

Drug does not reduce digital ulcers in patients with systemic sclerosis

Systemic sclerosis is a chronic multisystem autoimmune disease and multiorgan disease affecting the connective tissue of the skin and several internal organs. Digital ulcers occur in 35 percent to 68 percent of patients with systemic sclerosis and are associated with pain, disfigurement, poor quality of life, and disability. For this study, two clinical trials (DUAL-1, DUAL-2) were conducted in which patients with systemic sclerosis and active digital (finger) ulcers at trial entry were randomly assigned to receive oral doses of 3 mg of macitentan, 10 mg of macitentan, or placebo once daily and stratified according to number of digital ulcers at baseline. Macitentan is a drug approved for long-term treatment of pulmonary arterial hypertension.

In DUAL-1, among 289 randomized patients, 226 completed the study. Among 265 patients randomized in DUAL-2, 216 completed the study. The researchers found that macitentan did not reduce the cumulative number of new digital ulcers over 16 weeks compared with placebo. Regardless of treatment, patients had few new digital ulcers, and their overall digital ulcer condition remained stable over 16 weeks.

Adverse events more frequently associated with macitentan than with placebo were headache, peripheral edema, skin ulcer, anemia, upper respiratory tract infection and diarrhea.

More hot stories

Women less likely than men to receive CPR from passerby

If you suffer cardiac arrest in public, just being a woman means you’re less likely to receive potentially life-saving CPR from a passerby, according to a new study. One theory to explain the discrepancy: Strangers may be reluctant to undo a woman’s clothing and touch her breasts, even if it means...

Read More

A new yo-yo dieting danger: It can harm your heart, too

For overweight people with heart disease, trying and failing to lose weight may be more dangerous than not losing weight at all. A new retrospective study has concluded that patients whose weight fluctuates the most die twice as quickly or have twice the risk of heart attack or stroke compared to...

Read More

Prescription Weight Loss Drugs

Eating less and moving more are the basics of weight loss that lasts. For some people, prescription weight loss drugs may help. You'll still need to focus on diet and exercise while taking these drugs, and they're not for everyone. Doctors usually prescribe them only if your BMI is 30 or higher, or if it's at...

Read More